ロード中...
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
BACKGROUND: International guidelines recommend nintedanib (OFEV(®)) as an option for the treatment of idiopathic pulmonary fibrosis (IPF). OBJECTIVE: The objective of this study was to assess the cost effectiveness of nintedanib versus pirfenidone, N-acetylcysteine and best supportive care (BSC) for...
保存先:
| 出版年: | Pharmacoeconomics |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357477/ https://ncbi.nlm.nih.gov/pubmed/28039616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-016-0480-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|